Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Bijal Shah, MD, Moffitt Cancer Center

Advertisement

Articles by Bijal Shah, MD, Moffitt Cancer Center

Future Directions in Mantle Cell Lymphoma

ByBijal Shah, MD, Moffitt Cancer Center
June 24th 2020

ASCO 2020: ZUMA-2 Update

ByBijal Shah, MD, Moffitt Cancer Center
June 24th 2020

Bruton Tyrosine Kinase Inhibitors

ByBijal Shah, MD, Moffitt Cancer Center
June 24th 2020

A Look at ZUMA-2 Trial

ByBijal Shah, MD, Moffitt Cancer Center
June 24th 2020

An Introduction to Mantle Cell Lymphoma & KTE-X19

ByBijal Shah, MD, Moffitt Cancer Center
June 24th 2020
Advertisement

Latest Updated Articles

  • An Introduction to Mantle Cell Lymphoma & KTE-X19
    An Introduction to Mantle Cell Lymphoma & KTE-X19

    June 24th 2020

  • Future Directions in Mantle Cell Lymphoma
    Future Directions in Mantle Cell Lymphoma

    June 24th 2020

  • A Look at ZUMA-2 Trial
    A Look at ZUMA-2 Trial

    June 24th 2020

  • Bruton Tyrosine Kinase Inhibitors
    Bruton Tyrosine Kinase Inhibitors

    June 24th 2020

  • ASCO 2020: ZUMA-2 Update
    ASCO 2020: ZUMA-2 Update

    June 24th 2020



Advertisement
Advertisement

Trending on OncLive

1

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

2

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

3

Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026

4

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

5

First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us